Pravastatin or Atorvastatin Evaluation and Infection Therapy (TIMI22)
NCT00382460
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
4000
Enrollment
INDUSTRY
Sponsor class
Conditions
Actue Coronary Syndromes
Interventions
DRUG:
PRAVASTATIN SODIUM
Sponsor
Bristol-Myers Squibb